The Evok series is designed for use in sound therapy for tinnitus retraining therapy, masking, or other recognized forms of tinnitus treatment. Sound therapy should be used in concert with counseling from a physician, an audiologist or other qualified tinnitus specialists.

The target population for this product is primarily the adult population 18 vears of age and older. The target group for this product includes individuals reporting tinnitus who can also benefit from an air conduction hearing aid.

Device Description

Our devices are a combination of a hearing aid and a tinnitus masker in the same instrument. They are prescribed for those people with hearing loss who do not have significant relief with a hearing aid alone.

Dispenser or user adjustments permit selection of broad band or high or low frequency emphasis noise and aid response. It is essentially a tinnitus masker with a hearing aid added. Programmable volume controls are provided: one for noise level and the other for hearing aid gain. The dispenser, audiologist or user can mix the amount of noise and amplification as required.

AI/ML Overview

The provided document does not contain a study or data proving the device meets specific acceptance criteria. Instead, it is a 510(k) summary, which is a premarket notification to demonstrate that a device is substantially equivalent to a legally marketed predicate device.

Here's an analysis of the provided information in the context of your request:

1. A table of acceptance criteria and the reported device performance

Acceptance Criteria: The document does not explicitly state quantitative acceptance criteria (e.g., specific auditory thresholds, SNR, or masking effectiveness levels) based on which the device's performance was evaluated. The primary "acceptance criterion" for a 510(k) submission is showing substantial equivalence to predicate devices.
Reported Device Performance:
- The document states, "The non-clinical tests submitted in this 510(k) demonstrate the electroacoustic properties of our devices and how similar in test results parameters they are." However, specific electroacoustic parameters or numerical results are not provided in this summary.
- The document emphasizes the device's function: "The Evok 900 series are designed to provide tinnitus masking and amplification for hearing loss in the same device." Its effectiveness is inferred from its similarity to predicate devices that perform these functions.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

No specific test set or clinical study data is described. The submission relies on "non-clinical tests" demonstrating electroacoustic properties and the established safety record of Class I hearing aids. There is no mention of a human subject test set.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

Not applicable. No human subject test set or ground truth establishment by experts is described in this 510(k) summary.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

Not applicable. No human subject test set or adjudication method is described.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This device is a hearing aid/tinnitus masker, not an AI diagnostic tool that would typically involve human readers. No MRMC study is mentioned.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Not applicable in the AI sense. The device is a physical medical device. While it functions independently, it requires fitting and recommendations by a qualified hearing healthcare professional. Its "performance" refers to its acoustical output and masking capabilities, not an algorithmic assessment.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

No explicit ground truth established for a test set. The basis for substantial equivalence is the similarity in "materials, construction and internal circuits" and "electroacoustic properties" to predicate devices, and the established safety of Class I hearing aids. The "truth" here is essentially compliance with engineering specifications and demonstrated functional equivalence to existing, approved devices.

8. The sample size for the training set

Not applicable. This document describes a medical device, not a machine learning model, so there is no "training set."

9. How the ground truth for the training set was established

Not applicable. (See point 8)

Summary of Device and Evidence:

The Persona Medical Evok series (Evok 900, 913r, 923, 928, 933) is a combination hearing aid and tinnitus masker. The submission is a 510(k) premarket notification asserting substantial equivalence to existing predicate devices (General Hearing Instruments Tranquil Combo Devices and GN Resound TSG Module/Live TS series).

The "study that proves the device meets acceptance criteria" is primarily the non-clinical testing demonstrating the electroacoustic properties of the Evok devices and their similarity to the predicate devices. The document explicitly states:

"The non-clinical tests submitted in this 510(k) demonstrate the electroacoustic properties of our devices and how similar in test results parameters they are."
"Since these devices are basically Class I device Hearing Aids, the years these devices have been in market have established a safety track record that substantiates they are safe to market."
"The technological similarities to the predicate are based on the materials, construction and internal circuits used by Class I Hearing aids..."
"The testing performed on the Evok 900 series are evidence that these devices are safe when used in accordance with the guidance of a qualified audiologist or other hearing healthcare professional..."

The FDA's decision to clear the device (K093715) indicates that they agreed the device was substantially equivalent to the predicate devices based on this non-clinical data and the established safety records.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo for Persona Medical. The logo has the word "PERSONA" in all caps, with the "O" being a stylized image of a person. Below the word "PERSONA" is the word "MEDICAL" in smaller letters. Above the word "PERSONA" is the number K093715.

DEC 2 2 2010

510(k) Summary

Date: 12/17/10 510(K) Type: Traditional Device Type: Medical

APPLICANT:	Magnatone Hearing Aid Corp.dba Persona Medical
ADDRESS:	170 N. Cypress WayCasselberry, Fl. 32707
CONTACTS:	Don Campbell.President Persona Medicaldonc@personamedical.comPhone: 407-339-2422Fax: 407-339-5775
Trade Name:	Hearing Aid/Tinnitus MaskerDescribed in 21 CFR 874.3400
Product Code:	ESDKLW
Device Classification:	Class I (Air Conduction Hearing Aid)Class II (Tinnitus Masker)

{1}------------------------------------------------

Proprietary Name(s):

a) Evok 900 Full Shell Hearing Device w/Tinnitus Masker Option b) Evok 900 Half Shell/Canal Hearing Device w/ Tinnitus Masker Option

c) Evok 900 Mini Canal/CIC Hearing Device w/ Tinnitus Masker Option

d) Evok 913r Hearing Device w/ Tinnitus Masker Option

e) Evok 923 Hearing Device w/ Tinnitus Masker Option

f) Evok 928 Hearing Device w/ Tinnitus Masker Option

g) Evok 933 Hearing Device w/ Tinnitus Masker Option

Predicate Devices:

Our device is similar to the principles and tools/stimuli used by these predicate devices;

Manufacturer:	General Hearing Instruments.New Orleans, La.
Trade/Device Name:	Tranquil Combo Devices (Tinnitus ControHearing Instrument Combination)
Regulation Number:	21 CFR 874.3400
Regulation Name:	Tinnitus Masker/Hearing Aid
Regulatory Class:	Class II/Class I
Product Code:	KLW
510(k) Number:	K974751
Manufacturer:	GN Resound8001 Bloomington Freeway,Bloomington, MN55420
Trade/Device Name:	TSG ModuleAO970-DVIR, AO970-DVIRHP,AO971-DVI
Regulation Number:	21 CFR 874.3400
Regulation Name:	Tinnitus Masker/Hearing Aid
Regulatory Class:	Class II/Class I
Product Code:	KLW
510(k) Number:	K073636

{2}------------------------------------------------

Device Description:

Intended Use:

The Evok 900 series are designed for individuals who experience tinnitus and also have a hearing loss. The Evok 900 series are custom and standard air conduction hearing aids with the capacity to generate broad-band noise from its circuit. The broad-band noise generator is intended for tinnitus masking therapy. It is recommended that these devices be fit by a qualified audiologist or other hearing healthcare professional familiar with the diagnosis of tinnitus and subsequent rehabilitation therapy.

Target Population:

The target population for this product is the adult population 18 years of age and older. The target group for this product includes individuals reporting tinnitus who can also benefit from an air conduction hearing aid.

Technological Characteristics:

The technological similarities to the predicate are based on the materials, construction and internal circuits used by Class I Hearing aids in Behind The Ear or inside the ear canal (Custom). Another characteristic is that the Hearing Aid will have the option to be a Tinnitus masking sound generator. This is achieved by programmable acoustical properties contained in the hybrid circuit built into the device.

{3}------------------------------------------------

Non-Clinical Performance Data:

The non-clinical tests submitted in this 510(k) demonstrate the electroacoustic properties of our devices and how similar in test results parameters they are.

Since these devices are basically Class I device Hearing Aids, the years these devices have been in market have established a safety track record that substantiates they are safe to market.

Substantial equivalence:

The Evok 900 series are designed to provide tinnitus masking and amplification for hearing loss in the same device. This is also true for the General Hearing Tranquil custom devices and the GN Resound Live TS BTE, OTE and RIE (also referred to in the Hearing Aid industry as RIC) products.

The Evok 900 series, General Hearing Tranquil custom devices and the GN Resound Live TS all contain circuits which can be programmed to generate sound to the ear help mask the tinnitus and decrease the perceived tinnitus.

The Evok 900 series, General Hearing Tranquil custom devices and the GN Resound Live TS Tinnitus instruments combine the amplification of a hearing aid and the masking sound of a tinnitus masker.

Risk to health:

There is no known risk associated with the use of this device because the acoustical properties of the design do not allow amplification that is considered damaging in accordance with OSHA 29 CFR 1910.95.

Conclusion:

The testing performed on the Evok 900 series are evidence that these devices are safe when used in accordance with the guidance of a qualified audiologist or other hearing healthcare professional familiar with the diagnosis of tinnitus and subsequent rehabilitation therapy.

{4}------------------------------------------------

Image /page/4/Picture/1 description: The image shows the seal of the Department of Health & Human Services USA. The seal features a stylized eagle with three lines representing its wings, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" encircling the image. The text is arranged in a circular fashion around the eagle symbol.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Magnatone Hearing Aid Corp. dba Persona Medical c/o Mr. Don Campbell President Persona Medical 170 N. Cypress Way Casselberry, FL 32707

DEC 22 2010

Re: K093715

Trade/Device Name: Persona Medical Evok Tinnitus Masker Regulation Number: 21 CFR 874.3400 Regulation Name: Tinnitus masker Regulatory Class: Class II Product Code: KLW Dated: November 23, 2010 Received: November 30, 2010

Dear Mr. Campbell:

. . . .

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{5}------------------------------------------------

Page 2 - Mr./Ms./Mrs./Dr.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Debnal Falls

Malvina B. Eydelman, M.D.
Director

Director Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{6}------------------------------------------------

Indications for Use

510(k) Number: K093715

DEC 2 2 2010

Device Name:

1 ) Evok 900 Full Shell Hearing Device w/ Tinnitus Masker Option 2) Evok 900 Half Shell/Canal Hearing Device w/ Tinnitus Masker Option 3) Evok 900 Mini Canal/CIC Hearing Device w/ Tinnitus Masker Option 4) Evok 933 Behind The Ear Hearing Device w/ Tinnitus Masker Option 5) Evok 923 On the Ear Hearing Device w/ Tinnitus Masker Option 6) Evok 928 On the Ear Hearing Device w/ Tinnitus Masker Option 7) Evok 913r Receiver in Canal Hearing Device w/ Tinnitus Masker Option

Indications for Use:

NOTE: The Evok 900 series Tinnitus Masker Devices are targeted primarily to the adult population over 18 years old. Our User Guide does state this but it also has a statement that reads; "a child with a hearing loss should be directed to an Audiologist for evaluation and rehabilitation". This is not meant to be a contradiction considering the user guide is generic in the general information supplied to the end user.

As part of a Tinnitus Management Program, we suggest the following recommendations applicable to clinical settings for all the devices listed above;

The Tinnitus Management treatment should include evaluation and recommendations done by a qualified audiologist, otorhinolaryngologists or

{7}------------------------------------------------

other licensed hearing healthcare professional. Since tinnitus can be associated with a number of auditory conditions, the audiologic evaluation can yield extensive information regarding the possible cause for the tinnitus and options for a successful Tinnitus Management treatment.

Prescription Use (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use _ (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page 2 of 2

ShuChen keng. Ph.D CCCA
(Division Sign-Off)
Division of Ophthalmic, Neurological and Ear,
✓ Throat Devices

Division of Opination
Nose and Throat Devices

510(k) Number

Prescription Use Prescription 301.109)

Regulation Number and Section

§ 874.3400 Tinnitus masker.

(a)
Identification. A tinnitus masker is an electronic device intended to generate noise of sufficient intensity and bandwidth to mask ringing in the ears or internal head noises. Because the device is able to mask internal noises, it is also used as an aid in hearing external noises and speech.(b)
Classification. Class II. The special control for this device is patient labeling regarding:(1) Hearing health care professional diagnosis, fitting of the device, and followup care,
(2) Risks,
(3) Benefits,
(4) Warnings for safe use, and
(5) Specifications.